FDG-PET/CT in the monitoring of lymphoma immunotherapy response: current status and future prospects
Simple Summary Cancer immunotherapy is a type of cancer treatment that uses the immune
system to fight cancer cells. Some of these treatments stimulate the immune system, while …
system to fight cancer cells. Some of these treatments stimulate the immune system, while …
Combination Therapy with Immune Checkpoint Inhibitors and Histone Deacetylase Inhibitors or Alkylating Agents
M Joerger, KL Koster, T Janik… - Cancer Management and …, 2024 - Taylor & Francis
Purpose Immune checkpoint inhibitors (CPIs) have been widely adopted in a number of
early and advanced malignancies. Histone deacetylase inhibitors (HDACis) and alkylating …
early and advanced malignancies. Histone deacetylase inhibitors (HDACis) and alkylating …
Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+ AD) for Advanced Stage Classic Hodgkin Lymphoma: Updated Efficacy and Safety Results …
H Lee, IW Flinn, J Melear, R Ramchandren, J Friedman… - Blood, 2022 - ashpublications.org
Introduction Brentuximab vedotin (BV) and nivolumab are well tolerated and active
treatments for patients (pts) with classical Hodgkin lymphoma (cHL). These agents were …
treatments for patients (pts) with classical Hodgkin lymphoma (cHL). These agents were …